2021, Scientific Sessions, Session Coverage
  • Despite new findings, questions persist about cause and consequences of neonatal hypoglycemia

    Despite new findings, questions persist about cause and consequences of neonatal hypoglycemia

    Raghavendra Rao, MD, Charles Stanley, MD, Sarbattama Sen, MD, and Paul Rozance, MD, will address whether neonatal hypoglycemia is overdiagnosed or underestimated in this symposium.


  • Experts will weigh benefits, challenges of type 1 diabetes screening

    Experts will weigh benefits, challenges of type 1 diabetes screening

    A joint symposium of the ADA and the International Society for Pediatric and Adolescent Diabetes featuring Richard A. Oram, MD, PhD, and R. Brett McQueen, PhD, will consider general population screening versus targeted screening.


  • Session will outline practical steps for effective use of CGM in primary care

    Session will outline practical steps for effective use of CGM in primary care

    The data from continuous glucose monitoring devices can help patients make more informed decisions on lifestyle modifications, insulin dosing, and meal planning. Thomas W. Martens, MD, Dana Gershenoff, MS, RD, CDCES, and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, explain how.


  • Presenter Perspectives: Looping is for Everyone … Who Wants to Do It

    Presenter Perspectives: Looping is for Everyone … Who Wants to Do It

    Dana M. Lewis, BA, shared details about her presentation at the 81st Scientific Sessions on evidence supporting the use of open-source automated insulin delivery systems. “Many providers are still unaware of them as an option, or how they might support patients choosing to access these systems,” she said.


  • Presenter Perspectives: Stem Cell-Based Drug Discovery for Precision Medicine of Diabetes

    Presenter Perspectives: Stem Cell-Based Drug Discovery for Precision Medicine of Diabetes

    Shuibing Chen, PhD, shared details about this presentation, which begins Sunday, June 27, at 6:00 p.m. ET.


  • Pandemic highlights ‘epidemic’ of inequities facing youth with diabetes, says ADA President, Health Care & Education

    Pandemic highlights ‘epidemic’ of inequities facing youth with diabetes, says ADA President, Health Care & Education

    In her address Saturday, ADA President, Health Care & Education, Cynthia E. Muñoz, PhD, MPH, discussed how the ADA is addressing systemic health care disparities among children with diabetes.


  • Outstanding Educator award honors READY-Girls program creator

    Outstanding Educator award honors READY-Girls program creator

    Award recipient Denise Charron-Prochownik, PhD, RN, CPNP, recounted the 30-year history of Reproductive-health Education and Awareness of Diabetes in Youth for Girls. The program reinforces health care provider education and counseling.


  • Although incomplete, data indicate strong link between diabetes and COVID-19

    Although incomplete, data indicate strong link between diabetes and COVID-19

    The ADA Diabetes Care Symposium, with speakers Edward W. Gregg, PhD, and Linda DiMeglio, MD, MPH, focused on minimizing risks for people with diabetes during the pandemic. This population accounts for 30% to 40% of hospitalized COVID-19 patients.


  • Virtual Medical Center provides remote diabetes education to veterans, service members worldwide

    Virtual Medical Center provides remote diabetes education to veterans, service members worldwide

    Brian V. Burke, MD, FACP, Mary M. Julius, RDN, LD, CDCES, Stephanie De Leon Ansley, MS, RD, CSSD, LD, CDCES, and Brian James, MEd, explained how this avatar-to-avatar DSMES program operates.


  • PCOS treatment strategies must address both metabolic, psychological complications

    PCOS treatment strategies must address both metabolic, psychological complications

    Jerome F. Strauss III, MD, PhD, Erik A. Richter, MD, DMSci, Karen Elkind-Hirsch, MS, PhD, and Anuja Dokras, MD, PhD, reviewed advances in the diagnosis and care of women with polycystic ovary syndrome.